These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 28841151)

  • 1. CCR7 Sulfotyrosine Enhances CCL21 Binding.
    Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
    Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
    Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
    Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
    Front Immunol; 2019; 10():2156. PubMed ID: 31572374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
    Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of CCL21 and identification of a putative CCR7 binding site.
    Love M; Sandberg JL; Ziarek JJ; Gerarden KP; Rode RR; Jensen DR; McCaslin DR; Peterson FC; Veldkamp CT
    Biochemistry; 2012 Jan; 51(3):733-5. PubMed ID: 22221265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
    Hauser MA; Legler DF
    J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
    Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic Structure of Truncated CCL21 and the Putative Sulfotyrosine-Binding Site.
    Smith EW; Lewandowski EM; Moussouras NA; Kroeck KG; Volkman BF; Veldkamp CT; Chen Y
    Biochemistry; 2016 Oct; 55(40):5746-5753. PubMed ID: 27617343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into Molecular Recognition by Human Chemokine CCL19.
    Lewandowski EM; Kroeck KG; Jacobs LMC; Fenske TG; Witt RN; Hintz AM; Ramsden ER; Zhang X; Peterson F; Volkman BF; Veldkamp CT; Chen Y
    Biochemistry; 2022 Mar; 61(5):311-318. PubMed ID: 35156805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.
    Moussouras NA; Getschman AE; Lackner ER; Veldkamp CT; Dwinell MB; Volkman BF
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28869519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Features of an Extended C-Terminal Tail Modulate the Function of the Chemokine CCL21.
    Moussouras NA; Hjortø GM; Peterson FC; Szpakowska M; Chevigné A; Rosenkilde MM; Volkman BF; Dwinell MB
    Biochemistry; 2020 Apr; 59(13):1338-1350. PubMed ID: 32182428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding.
    Barmore AJ; Castex SM; Gouletas BA; Griffith AJ; Metz SW; Muelder NG; Populin MJ; Sackett DM; Schuster AM; Veldkamp CT
    Biochem Biophys Res Commun; 2016 Sep; 477(4):602-606. PubMed ID: 27338641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
    Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
    J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
    Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
    J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
    Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
    Database (Oxford); 2015; 2015():. PubMed ID: 26504105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine (C‑C motif) ligand 21/C‑C chemokine receptor type 7 triggers migration and invasion of human lung cancer cells by epithelial‑mesenchymal transition via the extracellular signal‑regulated kinase signaling pathway.
    Zhong G; Chen L; Yin R; Qu Y; Bao Y; Xiao Q; Zhang Z; Shen Y; Li C; Xu Y; Zou Z; Tian H
    Mol Med Rep; 2017 Jun; 15(6):4100-4108. PubMed ID: 28487957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
    Artinger M; Gerken OJ; Legler DF
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
    Jørgensen AS; Rosenkilde MM; Hjortø GM
    Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19.
    Haessler U; Pisano M; Wu M; Swartz MA
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5614-9. PubMed ID: 21422278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL21/CCR7 axis as a therapeutic target for autoimmune diseases.
    Han L; Zhang L
    Int Immunopharmacol; 2023 Aug; 121():110431. PubMed ID: 37331295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.